Relay Therapeutics Inc. Common Stock vs Veeva Systems — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B), while Veeva Systems trades at $285.41 (market cap $45.74B). The key difference: Veeva Systems is far larger — about 11.6× Relay Therapeutics Inc. Common Stock's market cap, and Veeva Systems is trading nearer its 52-week high, Relay Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Veeva Systems for 5 Days on average.
| RLAY | VEEV | |
|---|---|---|
Market Cap | $3.94B | $45.74B |
Volume | 3,432,928 | 1,118,315 |
Sector | Health | Technology |
52-Week High | $20.75 | $299.10 |
52-Week Low | $6.03 | $151.43 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $3.06B | $38.65B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →